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ABSTRACT Spin-labeled phospholipid analogs have been employed to probe the transbilayer distribution of endogenous
phospholipids in various membrane systems. To determine the transmembrane distribution of the spin-labeled analogs, the
analogs are usually inserted into the membrane of interest and subsequently the amount of analog in the outer membrane
leaflet is determined either by chemical reduction with ascorbate or by back-exchange to bovine serum albumin (BSA). For
accurate determination of the transbilayer distribution of analogs, both the kinetics of incorporation and those of accessibility
of analogs to ascorbate or BSA have to be fast in comparison to their transbilayer movement. By means of stopped-flow
electron paramagnetic resonance (EPR) spectroscopy, we have studied the kinetics of incorporation of the spin-labeled
phosphatidylcholine (PC) analog 1 -palmitoyl-2-(4-doxylpentanoyl)-sn-glycero-3-phosphocholine (SL-PC) and of its accessi-
bility to chemical reduction and to back-exchange at room temperature. Incorporation of SL-PC into the outer leaflet of egg
phosphatidylcholine (EPC) and red cell ghost membranes was essentially completed within 5 s. Ninety percent of the SL-PC
molecules located in the outer membrane leaflet of those membranes were extracted by BSA within 15 s. All exterior-facing
SL-PC molecules were reduced by ascorbate in a pseudo-first-order reaction within 60 s in EPC membranes and within 90 s
in red cell ghost membranes. The rate of the reduction process could be enhanced by -30-fold when 6-0-phenyl-ascorbic
acid was used instead of ascorbate as the reducing agent. The results are discussed in light of assaying rapid transbilayer
movement of spin-labeled analogs in biological membranes.
INTRODUCTION
Since the early work of Devaux and co-workers on the
human erythrocyte membrane (Seigneuret and Devaux,
1984; Seigneuret et al., 1984), spin-labeled phospholipids
have become an important tool for the determination of
transverse phospholipid distribution in biological mem-
branes (for recent reviews see, e.g., Zachowski, 1993, or
Menon, 1995). The phospholipid analogs developed for
those studies carry a long-chain fatty acid at the sn-1 posi-
tion and a short spin-labeled fatty acid at the sn-2 position
(Fig. 1) (Seigneuret et al., 1984; Fellmann et al., 1994). In
the absence of membranes, those analogs form micelles in
aqueous solutions with a critical micellar concentration of
-1 AM (King and Marsh, 1987). Although this behavior is
similar to that of lysolipids, numerous studies on a variety of
plasma membranes and subcellular membranes have dem-
onstrated that spin-labeled phospholipids are quite faithful
analogs of their biogenic counterparts (Zachowski et al.,
1987; Calvez et al., 1988; Morrot et al., 1989; Wu and
Hubbell, 1993), whereas spin-labeled lysolipids are not
(Morrot et al., 1989). As long as the membrane concentra-
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tion of spin-labeled phospholipids (Fig. 1) is low (<5 mol%
of endogenous lipids), cellular viability does not seem to be
impaired. For example, we have recently shown that the
motility of ram sperm cells was not affected after incorpo-
ration of analogs into the plasma membrane (Muller et al.,
1994).
The basic principle for probing the transbilayer distribu-
tion of spin-labeled phospholipid analogs is rather simple.
In aqueous buffer these analogs form a suspension with
coexisting populations of monomers and micelles. When
mixed with native or artificial membranes these spin-la-
beled phospholipids partition quantitatively into that leaflet
of a membrane bilayer that is exposed to the buffer (here-
after called the outer leaflet). Subsequently, the lipid ana-
logs may redistribute between the outer and inner leaflet by
various pathways, e.g., passive and/or ATP-dependent
mechanisms (Zachowski, 1993; Menon, 1995). As has been
shown for plasma membranes and subcellular membranes
of various cell types (see references above), the analogs
finally adopt a transmembrane distribution that is very close
to the distribution observed for endogenous phospholipids.
In principle, two experimental approaches for determining
the transbilayer distribution of spin-labeled phospholipids
have found widespread application. One way is to treat
labeled membranes with membrane-impermeant reagents
such as ascorbate to selectively reduce the NO moiety of the
spin-labeled analogs located in the outer membrane leaflet
to the corresponding nonparamagnetic hydroxylamine. This
so-called ascorbate assay was originally worked out by
1645
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exchange and the ascorbate assay, by employing stopped-
flow electron paramagnetic resonance (EPR) spectroscopy
with a dead time of 10 ms. We have determined the kinetics
1) of the incorporation of the spin-labeled analog 1-palmi-
toyl-2-(4-doxylpentanoyl)-phosphatidylcholine (SL-PC)
into liposomal and biological membranes, 2) of the back-
exchange of SL-PC from the outer bilayer leaflet to BSA,
and 3) of the reduction of the NO moiety of SL-PC localized
in the outer leaflet of liposomal and biological membranes
by ascorbate. To optimize the latter approach we examined
various ascorbate derivatives as reducing agents and found
that the rate of the reduction process can be significantly
enhanced by using 6-0-phenyl-ascorbic acid instead of the
usual ascorbate.
MATERIALS AND METHODS
Chemicals
sodium 6O-phenyl-
ascorbate ascorbic acid
FIGURE 1 Structures of 1-palmitoyl-2-(4-doxylpentanoyl)-phosphati-
dylcholine, sodium ascorbate, and of 6-O-phenyl-ascorbic acid.
Kornberg and McConnell (1971) for a spin-labeled phos-
phatidylcholine (PC) analog with the paramagnetic tetra-
methylpiperidine-l-oxyl group covalently bonded to the
quaternary ammonium group of choline. A prerequisite for
efficient reduction by ascorbate is that the NO group be
located close to the lipid-aqueous interface. The structure of
the phospholipid analog shown in Fig. 1 meets this condi-
tion (Seigneuret and Devaux, 1984; Seigneuret et al., 1984).
Alternatively, the population of spin label on the exterior
may be ascertained by back-exchange of exterior-facing
spin-labeled phospholipid analogs to bovine serum albumin
(BSA) (Calvez et al., 1988; Morrot et al., 1989). This
"back-exchange" assay was originally developed for extrac-
tion of lysolipids and fatty acids from membranes (Haest et
al., 1981).
The time resolution of the ascorbate and the back-ex-
change assay depends 1) on the rate of the incorporation of
the spin-labeled phospholipid analogs into membranes and
2) on the rate of the reduction (in the case of the ascorbate
assay) or the extraction (in the case of the back-exchange
assay) of the analogs that reside in the outer membrane
leaflet. Recent work on the rapid translocation of phospho-
lipids across the plasma membrane of sperm cells (Miller et
al., 1994) and the membrane of rat liver endoplasmic retic-
ulum (Buton et al., 1996) clearly demonstrates the need for
assaying the transbilayer phospholipid distribution on a
rapid time scale. Unfortunately, quantitative data character-
izing the time dependence of the incorporation and the
accessibility of spin-labeled phospholipid analogs are not
available.
In the present study we were able to define an upper limit
for the time resolution that is achievable with the back-
Egg phosphatidylcholine (EPC), KCI, MgCl2, NaCl, Na2HPO4, NaH2PO4,
sodium ascorbate, and BSA were purchased by Sigma (Deisenhofen,
Germany). Tris was obtained from Fluka (Neu-Ulm, Germany). Phosphate-
buffered saline (PBS) contained 150 mM NaCl and 5.8 mM Na2HPO4/
NaH2PO4 (pH 7.4).
Synthesis of SL-PC and 6-0-phenyl-ascorbic acid
SL-PC and 6-O-phenyl-ascorbic acid (Fig. 1) were synthesized as de-
scribed previously (Fellmann et al., 1994; Wimalasena et al., 1994).
Preparation of unlabeled small unilamellar
phospholipid vesicles
An appropriate amount of EPC dissolved in chloroform/methanol (9:1, v/v)
was dried under nitrogen and resuspended at a concentration of 4 mM in
low salt buffer (LSB) (50 mM Tris, 25 mM KCI, 5 mM MgCl2, pH 7.5).
The resulting phospholipid dispersion was sonicated for 30 min with the
microtip of a Branson Sonifier model W 250 (Carouge-Geneve, Switzer-
land) at an output control setting of 2 and 50% duty cycle in a glass tube
cooled in an ice bath.
Preparation of spin-labeled small
unilamellar vesicles
Small unilamellar vesicles (SUVs) containing SL-PC in both leaflets of the
membrane bilayer (symmetrically labeled vesicles) were prepared by mix-
ing 2 ,tmol of EPC with 0.1 ,umol of SL-PC, all dissolved in chloroform/
methanol (9:1, vlv). The phospholipid mixture was dried under nitrogen,
and the phospholipids were resuspended in 1 ml of LSB. Symmetrically
labeled SUVs were made by sonicating the resulting phospholipid disper-
sion for 30 min on ice as already described for unlabeled small unilamellar
EPC vesicles (see above). SUVs containing SL-PC only in the outer leaflet
of the membrane bilayer (asymmetrically labeled vesicles) were made by
preparing unlabeled small unilamellar EPC vesicles (4 mM EPC) as
described above and by mixing them with an equal volume of 0.2 mM
SL-PC in LSB.
Preparation of human erythrocyte ghosts
Unsealed erythrocyte ghosts were prepared according to the method of
Dodge et al. (1963). After removal of plasma and buffy coat, erythrocytes
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were washed twice in PBS at 2000 X g and finally resuspended to a 50%
hematocrit. Lysis was performed at 4°C by dilution of 4 ml ice-cold
suspension of erythrocytes (50% packed) with 60 ml ice-cold lysis buffer
(5.8 mM NaH2PO4/Na2HPO4, pH 7.4). Unsealed ghosts were collected by
centrifugation at 25,000 X g for 10 min and washed with ice-cold PBS.
Concentration of ghost proteins was determined according to the method of
Lowry et al. (1951). A weight ratio of ghost proteins to ghost endogenous
phospholipids of 1:1 was assumed.
Stopped-flow experiments
All experiments were carried out at room temperature with a commercially
available EPR stopped-flow accessory (Center of Scientific Instruments of
the former Academy of Sciences, Berlin-Adlershof) attached to a X-band
EPR spectrometer (type ERS 300 E; Bruker Analytische Messtechnik
GmbH, Karlsruhe, Germany). The following parameters were always used:
power 20 mW, modulation frequency 100 kHz, modulation amplitude '4
G. The stopped-flow accessory was specifically designed for use in EPR
spectroscopy, meeting the typical demands of biological applications, e.g.
small consumption of substance, avoidance of any contact of the reactants
with metal, and use of aqueous systems (Klimes et al., 1980). For com-
mercial production this original laboratory device was improved by a
pressure-resistant cylindrical capillary EPR cell and by the installation of a
stopping valve. This device has also been applied in enzymology, e.g., for
detection and characterization of a transient inhibitor radical of ribonucle-
otide reductase (Lassmann et al., 1992). The EPR cell is a thick-walled
cylindrical quartz capillary with a 1.3-mm inner diameter (sample volume:
30 ,ul) connected immediately with the mixer. The cylindrical capillary
EPR cell allows the connection of the stopped-flow accessory to any
rectangular standard H102-X-band cavity with a 11-mm sample hole. One
mixing shot needs 70 ,ul of each of the liquid components, which are stored
in glass syringes (1.6 ml each). Stroking magnets drive the two components
through the mixer and the EPR cell. Behind the EPR cell the flow is
stopped by an electrically controlled stopping valve, setting the trigger to
record a time sweep. The mixing takes - 1 ms and the dead time (time
between mixing and entering the EPR cell) another 1 ms. Although the
stopping time is only 0.5 ms, the stopping valve causes mechanical dis-
turbances that have an impact on the microwave detection system and last
some milliseconds. The overall time resolution of the apparatus has been
measured to be 10 ms, that is 10 ms after the trigger is set to record a time
sweep, the EPR signal is free of any disturbance from the stopped-flow
accessory.
Incorporation of SL-PC into membranes
To measure the time-dependent incorporation of SL-PC into membranes,
SL-PC was resuspended at a concentration of 0.2 mM in LSB and mixed
with an equal volume of a suspension of unlabeled EPC SUVs (4 mM
EPC) or an equal volume of a ghost suspension (4 mM ghost phospholipid)
in the stopped-flow accessory. The kinetics of incorporation was followed
by measuring the change of the EPR amplitude at a position corresponding
to the maximum of the high-field peak of the SL-PC membrane spectrum
(see also Results, Fig. 2). Kinetics in Fig. 3 were fitted to the following
biexponential function:
IEPR = a * (1 - ek*t) + b * (1 - -k2*t)
where t is the time and IEPR is the signal intensity, which is proportional to
the amount of incorporated SL-PC (see below).
Accessibility of membrane-incorporated SL-PC to
BSA, ascorbate, and 6-0-phenyl-ascorbic acid
BSA extraction of SL-PC from asymmetrically labeled EPC vesicle mem-
branes or from red cell ghost membranes was monitored by mixing
asymmetrically labeled EPC vesicles (2 mM EPC, 0.1 mM SL-PC) or
A
B-W
C
lOG
high-field peak
FIGURE 2 Incorporation of SL-PC into EPC vesicle membranes and red
cell ghost membranes. The top spectrum (A) is the spectrum of SL-PC in
aqueous buffer. Spectrum B was recorded after quantitative incorporation
of SL-PC into EPC vesicle membranes (molar ratio SL-PC:EPC = 5:100).
Spectrum C was recorded after incorporation of SL-PC into red cell ghost
membranes (molar ratio SL-PC to ghost phospholipids = 5:100). All
spectra were recorded at room temperature. The specific parameters of
EPR measurement were: conversion time, 81.92 ms (A, B), 163.64 ms (C);
time constant, 20.48 ms (A, B), 40.96 ms (C).
labeled ghosts (2 mM ghost phospholipid, 0.1 mM SL-PC) with an equal
volume of 10% (w/v) BSA in LSB in the stopped-flow cell. The time-
dependent decrease of the EPR amplitude at a position corresponding to the
maximum of the low-field peak of the SL-PC membrane spectrum (see also
Results, Figs. 7 and 8) reflects the kinetics of BSA extraction. Reduction
of the EPR signal of SL-PC in spin-labeled ghosts or in symmetrically or
asymmetrically labeled EPC vesicles due to ascorbate or 6-O-phenyl
ascorbic acid was monitored by mixing a suspension of labeled ghosts (2
mM ghost phospholipid, 0.1 mM SL-PC) or a suspension of the respective
labeled vesicles (2mM EPC, 0.1 rmM SL-PC) with an equal volume of 100
mM sodium ascorbate or 20 mM 6-O-phenyl ascorbic acid in LSB in the
stopped-flow cell. The time-dependent decrease in EPR amplitude at a
position corresponding to the maximum of the low-field peak (see also
Results, Figs. 4 and 5) was taken as a measure of SL-PC reduction.
6-O-Phenyl-ascorbic acid is considerably more acidic than sodium ascor-
bate. To preclude any influence of the pH on the rate of spin-label
reduction, 6-O-phenyl ascorbic acid solutions were adjusted to a pH of 7.5
with sodium hydroxide before the experiments.
RESULTS
Time course of SL-PC incorporation into EPC
vesicle membranes and red cell
ghost membranes
The EPR spectrum of SL-PC in buffer is shown in Fig. 2 A.
It is a composite spectrum consisting of a broad component
and a very narrow triplet. The broad component is due to
strong spin-spin interaction arising from SL-PC organized
in micelles. The narrow triplet is caused by SL-PC mono-
mers rapidly tumbling in buffer. Upon the addition of aque-
ous dispersed SL-PC to unlabeled EPC vesicles or red cell
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FIGURE 3 (Curve A) Kinetics of the incorporation of SL-PC into EPC
vesicle membranes at room temperature (molar ratio SL-PC:EPC = 5:100).
The solid line was obtained by fitting the data to a biexponential function
(see Materials and Methods) with the following parameters: a = 71.8%,
b = 26.4%, k, = 6.21 s-', k2 = 0.32 s-'. (Curve B) Kinetics of the
incorporation of SL-PC into red cell ghost membranes at room temperature
(molar ratio SL-PC to ghost phospholipids = 5:100). The solid line was
obtained by fitting the data to a biexponential function (see Materials and
Methods) with the following parameters: a = 72.3%, b = 26.6%, k, = 5.63
s- , k2 = 0.30 s- . The specific parameters of EPR measurement were (A,
B): conversion time, 20.48 ms; time constant, 5.12 ms. The time interval
between two data points is 20.48 ms in both kinetics.
ghosts (molar ratio SL-PC to EPC or ghost phospholipids =
5: 100), all analogs became incorporated into the membrane,
as indicated by a typical membrane spectrum (Fig. 2, B
and C).
To monitor the kinetics of incorporation of analogs into
EPC vesicle membranes or ghost membranes by EPR
stopped-flow spectroscopy, we set the magnetic field to a
position corresponding to the maximum of the high-field
peak of the membrane spectrum (see marking line in Fig. 2).
A comparison between the SL-PC membrane spectra (Fig.
2, B and C) and the spectrum of the analog in aqueous buffer
(Fig. 2 A) revealed that at this field strength the incorpora-
tion of SL-PC into EPC or ghost membranes was accom-
panied by a significant change in the EPR amplitude. Thus
the kinetics of incorporation of SL-PC could be measured
by monitoring the increase in amplitude as a function of
time. The result of such a stopped-flow experiment per-
formed with SL-PC and EPC vesicles is shown in Fig. 3 A.
An analogous experiment is shown with ghosts in Fig. 3 B.
Equal volumes of an aqueous SL-PC dispersion and a
suspension of EPC vesicles or ghosts were rapidly mixed
and injected into the EPR stopped-flow cell (see Materials
and Methods). From Fig. 3, A and B, it can be deduced that
90% of the SL-PC analogs became incorporated into EPC
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FIGURE 4 (Curve A) Kinetics of the reduction of SL-PC in symmetri-
cally labeled EPC vesicles (molar ratio SL-PC:EPC = 5:100) by 50 mM
sodium ascorbate (final concentration) at room temperature. The solid line
was obtained by fitting the data to Eq. 1. (Curve B) Kinetics of the
reduction of SL-PC in asymmetrically labeled EPC vesicles (molar ratio
SL-PC:EPC = 5:100) by 50 mM sodium ascorbate (final concentration) at
room temperature. The solid line was obtained by fitting the data to Eq. 2.
The specific parameters of EPR measurement were (A, B): conversion
time, 81.92 ms; time constant, 40.96 ms. The time interval between two
data points is 81.92 ms in both kinetics. (Inset) Spectrum of SL-PC
incorporated into the membrane of EPC vesicles (molar ratio SL-PC:
EPC = 5:100).
vesicle membranes and ghost membranes within 5 s at room
temperature. Kinetics could be fitted by a biexponential
function (see Materials and Methods as well as legend to
Fig. 3) with rate constants on the order of 6 s- and 0.3 s-1,
respectively. The corresponding amplitudes were -72%
and 27%, respectively. After the incorporation kinetics of
SL-PC was measured, its EPR spectrum was recorded di-
rectly in the stopped-flow cell. Both in the case of EPC
vesicles and in the case of ghosts a typical membrane
spectrum was found, confirming the complete incorporation
of the analogs into EPC and ghost membranes.
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FIGURE 5 Kinetics of the reduction of SL-PC in red cell ghost mem-
branes (molar ratio SL-PC to ghost phospholipids = 5:100) by 50 mM
sodium ascorbate (final concentration) at room temperature. The specific
parameters of EPR measurement were: conversion time, 163.84 ms; time
constant, 40.96 ms. The solid line was obtained by fitting the data to Eq.
2. The time interval between two data points is 163.84 ms. (Inset) Spectrum
of SL-PC incorporated into the membrane of red cell ghosts (molar ratio
SL-PC to ghost phospholipids = 5:100).
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To verify that the measured kinetics indeed reflects the
incorporation of the analog into membranes but not alter-
ations due to technical limitations of the stopped-flow
equipment (such as mixing time, mechanical disturbance,
etc.; see Materials and Methods), we have recorded the
time-dependent change of the high-field peak amplitude
upon mixing of SL-PC suspension with buffer (dilution, no
vesicles). In that case alterations of EPR amplitude were
found only for t < 10 ms, whereas for later times the
amplitude remained constant (data not shown).
Reduction of SL-PC in EPC membranes
by ascorbate
EPC vesicles labeled exclusively on their outer leaflet with
SL-PC (subsequently called "asymmetrically labeled") were
prepared by mixing SL-PC in buffer with unlabeled EPC
vesicles (see Materials and Methods). In phospholipid
membranes transbilayer diffusion of phospholipids such as
PC is very slow, with half-times on the order of hours or
days at room temperature (Op den Kamp, 1979). Indeed, our
data confirm that in asymmetrically labeled vesicles all
SL-PC molecules remained in the outer leaflet during the
time course of our experiments. We have mixed asymmetri-
cally labeled EPC vesicles with an equal volume of 100 mM
ascorbate in the EPR stopped-flow cell (see Materials and
Methods) and have followed the amplitude of the low-field
peak (see arrow in the inset of Fig. 4) as a function of time
at room temperature. Because ascorbate reduces the NO
moiety of SL-PC to the corresponding nonparamagnetic
hydroxylamine, the low-field peak amplitude decreases and,
in the case of asymmetrically labeled vesicles, eventually
disappears. Fig. 4 B displays the time-dependent decrease of
the low-field peak EPR amplitude for asymmetrically la-
beled EPC vesicles. After recording of the kinetics, the EPR
spectrum of SL-PC could no longer be detected, confirming
the complete reduction of the analog by ascorbate (data not
shown). This is consistent with the SL-PC being localized
exclusively in the outer leaflet of asymmetrically labeled
EPC vesicles. Additional support for that conclusion is
given by experiments on "symmetrically labeled" vesicles
(see below).
The kinetics of the reduction process can be described by
a reaction that is first order in both SL-PC and ascorbate
(see also Wu and Hubbell, 1993). The concentration of
nonreduced label at a given time is [Ntot] and corresponds to
the sum of intact label on the outer [No] and inner [Ni]
leaflet. At the time of ascorbate addition (t = 0 s), [Ntot]t = 0
is 100%. If one assumes the SL-PC that is located in the
inner vesicle leaflet is inaccessible to ascorbate, the relevant
rate equation is
[Ntot] = ([Ntot]t=o - [N])e-k[asco]t + [Ni] (1)
where [asco] is the concentration of ascorbate on the exte-
rior of the vesicle and kr is the rate constant for the reduc-
tion. In the case of asymmetrically labeled vesicles ([Ni] =
0%), the rate equation simplifies to
[Ntot] = [Ntot]t=oe-jk[asco]t (2)
The concentration of ascorbate [asco] is in large excess over
the concentration of SL-PC and may therefore be taken to
be constant. Thus the reduction process is pseudo-first-order
with respect to SL-PC, and the reduction of curve B in Fig.
4 can be fit well by a single exponential. The half-time tI,2
is given by
1
kr[asco] (3)
At room temperature, t112 of the reduction of SL-PC in
asymmetrically labeled EPC was 9.7 s at 50 mM ascorbate
(final concentration), and the respective rate constant kr was
1.42 M-1 s-1 (see also Table 1).
For comparison, "symmetrically labeled" EPC vesicles
were made by including SL-PC during vesicle preparation
(see Materials and Methods). Under this condition, the
distribution of the paramagnetic analog mimics the transbi-
layer distribution of EPC across the vesicle bilayer. Curve A
in Fig. 4 shows the reduction of SL-PC in symmetrically
labeled EPC vesicles after they are mixed with an equal
volume of 100 mM ascorbate in the stopped-flow accessory
at room temperature as described above. In the case of
symmetrically labeled vesicles, the amplitude of the low-
field peak did not decay to zero, as in the case of asym-
TABLE 1 Reduction of SL-PC in the outer leaflet of EPC vesicles and red cell ghost membranes by ascorbate and 6-0-phenyl-
ascorbic acid at room temperature
Membrane [Ni] (%) Reducing agent [asco] (mM) t1/2 (s) kr (M-is- )
EPC vesicles (asymmetrical) 0 Ascorbate 50 9.7 + 0.1 1.42 + 0.02
EPC vesicles (symmetrical) 28 + 3 Ascorbate 50 9.5 + 0.4 1.46 ± 0.06
Red cell ghosts (asymmetrical) ND Ascorbate 50 14.5 + 0.5 0.96 ± 0.03
EPC vesicles 0 6-O-Phenyl-ascorbic acid 10 1.6 0.1 42.49 ± 0.43
Measurements were performed by means of a stopped-flow accessory attached to an EPR spectrometer as described in Materials and Methods. [asco]
corresponds to the concentration of the reducing agent. The reduction rate constants kr (see Eqs. 1 and 2) and the half-times t/2 of reduction (see Eq. 3)
were obtained by fitting the experimental kinetics to Eq. 1 (symmetrically labeled vesicles) or Eq. 2 (asymmetrically labeled vesicles). Data represent the
average + SD of three independent experiments.
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metrically labeled vesicles (see Fig. 4, curve B), but re-
mained constant at a level of 28% of the initial label
concentration [Nt,t1t = 0. After reaching the plateau, we have
followed the remaining EPR spectrum for an additional 5
min at room temperature. We found no further decrease in
intensity. Such a stable, time-independent plateau value is
consistent with a negligible permeability of EPC vesicles
for ascorbate, even at room temperature.
One may wonder whether part of the vesicles became
(transiently) leaky because of mechanical stress by shearing
forces during rapid mixture in the EPR stopped-flow acces-
sory, which could cause a partial reduction of SL-PC in the
inner monolayer. This can obviously be ruled out, because
we obtained the same fraction of nonreducible SL-PC when
symmetrically labeled vesicles were gently mixed with
ascorbate and then transferred to a conventional EPR quartz
capillary. Therefore, the observed plateau value of 28% of
the initial label concentration can be attributed to SL-PC
that is located in the inner monolayer of the EPC vesicle
membranes. We fit the reduction kinetics in Fig. 4 A to Eq.
1. [Ntot] is 100% at the time of ascorbate addition. [Ni] =
28% is given by the plateau value in Fig. 4 A, and, as the
ascorbate penetration through EPC bilayers is negligibly
small at room temperature, [Ni] can be treated as a constant.
As expected, we obtained almost the same values for the
half-time t112 and for the rate constant kr of reduction of
SL-PC in the outer monolayer by 50 mM ascorbate (final
concentration) as for asymmetrically labeled vesicles (t112 =
9.5 s, kr = 1.46 M-1 s l; see also Table 1).
Reduction of SL-PC in red cell ghost membranes
We have measured the SL-PC reduction kinetics in unsealed
human erythrocyte ghosts. After labeling with SL-PC, the
ghosts were mixed with an equal volume of 100 mM ascor-
bate in the stopped-flow cell at room temperature as de-
scribed above. Fig. 5 shows the time-dependent reduction of
SL-PC in ghost membranes by ascorbate. All SL-PC mol-
ecules were accessible to ascorbate. The latter was con-
firmed in that no EPR signal could be detected when the
EPR spectrum was recorded a few minutes after the ascor-
bate treatment (data not shown). The kinetics can be fit well
by Eq. 2. This suggests that all SL-PC molecules were
oriented to the exoplasmic leaflet. Indeed, the transbilayer
movement of SL-PC in red blood cell membranes is a very
slow, passive process (Seigneuret and Devaux, 1984; Mor-
rot et al., 1989). We cannot rule out the possibility that holes
of leaky ghosts may provide a site of accelerated transbi-
layer movement, and thus a small amount of SL-PC may
have redistributed to the inner leaflet. However, in that case
it is reasonable to assume that ascorbate could rapidly
penetrate across leaky ghost membranes, reducing SL-PC in
the inner leaflet with the same efficiency as in the outer
leaflet. Otherwise, the reduction reaction should not be
describable by a monoexponential function. We found that
the reduction of SL-PC in red cell ghost membranes was
slower than in EPC vesicle membranes (t,12 = 14.5 s
compared to, e.g., t112 = 9.7 s in asymmetrically labeled
EPC vesicles; see also Table 1). The rate constant kr for the
reduction of SL-PC in ghost membranes was 0.96 M- s-1
(see also Table 1).
Reduction of SL-PC in EPC membranes by
6-0-phenyl-ascorbic acid
Fig. 6 (curve B) shows the kinetics of reduction of EPC
vesicles asymmetrically labeled with SL-PC by 6-O-phenyl-
ascorbic acid. Equal volumes of asymmetrically labeled
EPC vesicles and 20 mM 6-O-phenyl-ascorbic acid were
mixed in the stopped-flow cell, and the decrease in the
low-field peak amplitude was followed as a function of time
at room temperature as described above. We found that the
reduction of SL-PC by 6-O-phenyl ascorbic acid was much
faster in comparison to that by ascorbate, even at a fivefold
lower concentration (10 mM final concentration in the case
of 6-O-phenyl-ascorbic acid compared to 50 mM final con-
centration in the case of ascorbate; see Materials and Meth-
ods). In less than 10 s, the EPR signal of SL-PC disappeared
completely, which was confirmed by recording a total spec-
trum a few minutes after the addition of 6-O-phenyl-ascor-
bic acid. The reduction was pseudo-first-order with respect
to SL-PC, and the reduction curve could be fit by a single
exponential according to Eq. 2 with a half-time t112 of 1.6 s
at room temperature (see also Table 1). The rate constant kr
for the reduction of asymmetrically labeled vesicles with
6-O-phenyl-ascorbic acid (kr = 42.49 M-1 s-1) was -30-
fold higher in comparison to kr for the reduction of asym-
metrically labeled vesicles with ascorbate (kr = 1.42 M- 1 s- l).
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FIGURE 6 (Curve A) Kinetics of the reduction of SL-PC in symmetri-
cally labeled EPC vesicles (molar ratio SL-PC:EPC = 5:100) by 10 mM
6-O-phenyl-ascorbic acid (final concentration) at room temperature.
(Curve B) Kinetics of the reduction of SL-PC in asymmetrically labeled
EPC vesicles (molar ratio SL-PC:EPC = 5:100) by 10 mM 6-O-phenyl-
ascorbic acid (final concentration) at room temperature. The solid line was
obtained by fitting the data to Eq. 2. The specific parameters of EPR
measurement were (A, B): conversion time, 163.84 ms; time constant,
40.96 ms. The time interval between two data points is 163.84 ms in both
kinetics. (Inset) Spectrum of SL-PC incorporated into the membrane of
EPC vesicles (molar ratio SL-PC:EPC = 5:100).
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Fig. 6 (curve A) shows the disappearance of the EPR
signal of SL-PC in symmetrically labeled EPC vesicles in
the presence of 10 mM 6-O-phenyl-ascorbic acid (final
concentration) at room temperature. Again, we found a
rapid decay of the EPR signal corresponding to reduction of
SL-PC located in the outer leaflet. However, in contrast to
similar experiments with ascorbate (see Fig. 4 A), we did
not observe a stable plateau corresponding to the SL-PC on
the inner leaflet, but a further, slower continuous, and,
finally, complete loss of the EPR signal. We surmise that at
room temperature, 6-O-phenyl-ascorbic acid penetrates
slowly through the bilayer ofEPC vesicles, causing the slow
reduction of SL-PC located in the intravesicular leaflet. By
extrapolation of the second slow rate component to zero
time, it could be shown that -26% of the SL-PC are located
in the inner leaflet of symmetrically labeled EPC vesicles.
This value is consistent with that obtained from the data in
Fig. 4 A. We could demonstrate by conventional EPR spec-
troscopy (without stopped-flow mixing) that the permeation
of 6-O-phenyl-ascorbic acid was strongly temperature de-
pendent. At 0°C 6-O-phenyl-ascorbic acid did not penetrate
through EPC vesicle bilayers, and a stable plateau corre-
sponding to SL-PC analogs on the outer leaflet was ob-
served (data not shown). Even at this low temperature,
reduction of SL-PC by 6-O-phenyl-ascorbic acid was too
rapid to resolve into the corresponding kinetics with con-
ventional EPR spectroscopy.
Extraction of SL-PC from the outer membrane
leaflet of EPC vesicles and red cell ghosts
The EPR spectrum of SL-PC incorporated into the outer
leaflet of asymmetrically labeled EPC vesicles is shown in
Fig. 7 A. Upon mixing of these vesicles with an equal
low-field peak
FIGURE 7 Extraction of SL-PC from the outer leaflet of asymmetrically
labeled EPC vesicles (molar ratio SL-PC:EPC = 5:100) by BSA. The top
spectrum (A) was recorded after quantitative incorporation of SL-PC into
the outer leaflet of EPC vesicles (conversion time, 81.92 ms; time constant,
20.48 ms; time interval between two data points, 81.92 ms). The bottom
spectrum (B) was recorded after quantitative extraction of the SL-PC from
the outer membrane leaflet of the above-mentioned EPC vesicles by 5%
(w/v) BSA (final concentration) (conversion time, 163.84 ms; time con-
stant, 40.96 ms; time interval between two data points, 163.84 ms). Both
spectra were recorded at room temperature.
volume of 10% (w/v) BSA, the spectrum in Fig. 7 B was
obtained. As mixing of SL-PC in buffer with 10% (w/v)
BSA (data not shown) yielded a spectrum that is identical to
the spectrum in Fig. 7 B, we conclude that all SL-PC
molecules initially located in the outer leaflet of asymmetri-
cally labeled vesicles were extracted by BSA. We have
performed the same set of experiments with red cell ghosts
and we obtained analogous results. Upon mixing of ghosts
labeled with SL-PC with 10% (w/v) BSA, all SL-PC mol-
ecules located in the red cell ghost membranes were ex-
tracted by BSA (data not shown). Because the spectrum of
SL-PC bound to BSA is more immobilized in comparison to
the typical SL-PC membrane spectra obtained with ghosts
or EPC vesicles (see Fig. 7, A and B, data for ghosts not
shown), a decrease in the EPR amplitude of the low-field
peak (see marking line, Fig. 7) is observed upon back-
exchange of SL-PC from EPC vesicle or ghost membranes
to BSA. Thus the kinetics of extraction of SL-PC from the
outer leaflet of EPC vesicle or ghost membranes could be
determined by mixing EPC vesicles asymmetrically labeled
with SL-PC or ghosts labeled with SL-PC with an equal
volume of 10% (v/w) BSA in the stopped-flow cell and
monitoring the time-dependent decrease in the low-field
peak amplitude at room temperature (see Materials and
Methods). Fig. 8 displays the kinetics of extraction of
SL-PC from the outer membrane leaflet of asymmetrically
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FIGURE 8 (Curve A) Kinetics of the extraction of SL-PC from the outer
membrane leaflet of asymmetrically labeled EPC vesicles (molar ratio
SL-PC:EPC = 5:100) by 5% (w/v) BSA (final concentration) at room
temperature. (Curve B) Kinetics of the extraction of SL-PC from red cell
ghost membranes (molar ratio SL-PC to ghost phospholipids = 5:100) by
5% (w/v) BSA (final concentration) at room temperature. The specific
parameters of EPR measurement were (A, B): conversion time, 81.92 ms;
time constant, 40.96 ms. The time interval between two data points is 81.92
ms in both kinetics.
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labeled EPC vesicles (curve A) or from the membrane of
labeled ghosts (curve B). In both EPC and ghost mem-
branes, 90% of the SL-PC molecules were extracted by
BSA within 15 s at room temperature.
DISCUSSION
Spin-labeled phospholipid analogs with a long fatty acid
chain in the sn-i position and a short-chain fatty acid
bearing the NO moiety in the sn-2 position have been
successfully employed for investigating the transbilayer
motion and distribution of phospholipids in plasma and
subcellular membranes of various mammalian cells. Similar
phospholipid analogs with the fluorescent 4-nitrobenzo-2-
oxa-1,3-diazole group attached to the short fatty acid chain
have become an important tool for studying phospholipid
dynamics by fluorescence microscopy and spectroscopy
(Martin and Pagano, 1987; Connor et al., 1990).
Different assays have been employed to measure the
transbilayer redistribution of spin-labeled phospholipid an-
alogs. In particular, the ascorbate assay and the back-ex-
change assay have been established for measuring the trans-
membrane distribution in a variety of plasma and
subcellular membranes. Devaux (1991) has pointed out that
the steady-state transmembrane distribution that is observed
for phospholipid analogs results from a subtle balance be-
tween analogs redistributing from the outer to the inner
membrane leaflet and vice versa. Thus both the incorpora-
tion of spin-labeled analogs into the membrane and the
assay reactions for determining their transmembrane distri-
bution have to be faster than the above-mentioned inward
and outward movements. Whereas these preconditions seem
to be fulfilled for the plasma membrane of a variety of
mammalian cells such as erythrocytes (Seigneuret and De-
vaux, 1984; Calvez et al., 1988) or fibroblasts (Pomorski et
al., 1996), we have shown recently that the rate of the
aminophospholipid translocase-mediated translocation of
spin-labeled aminophospholipid analogs from the exoplas-
mic to the cytoplasmic leaflet of the plasma membrane of
ram sperm cells is close to the time resolution of the
back-exchange assay (Muller et al., 1994). Moreover, the
transbilayer movement of phospholipid analogs in various
subcellular membranes can be very fast, with half-times on
the order of minutes (Wu and Hubbell, 1993) or even less
than 1 min. For instance, Dolis et al. (1996) have reported
that radioactively labeled PC redistributes across the outer
membrane of rat liver mitochondria with a half-time of 2
min at 30°C. Buton et al. (1996) have reported that spin-
labeled phospholipid analogs redistribute across the mem-
brane of the endoplasmic reticulum of rat liver with a
half-time of 25 s at 20°C (PC and phosphatidylserine) and
20 s at 20°C (phosphatidylethanolamine). To our knowl-
edge this is the fastest translocation of spin-labeled analogs
observed so far in biological membranes. A main prerequi-
site for the validity of the above-mentioned studies is that 1)
brane and 2) the translocation assays are fast in comparison
to the transbilayer movement of the analogs.
Here we have provided quantitative kinetic data on the
incorporation of SL-PC into membranes as well as on
assaying its transbilayer distribution, employing a stopped-
flow EPR accessory with a dead time of 10 ms. Although
this equipment suffers from the drawback of lacking a
thermostat facility, it allows us to obtain detailed informa-
tion on the limit of the spin-labeling approach outlined
above. For the present purpose, in addition to liposomes, we
have used erythrocyte ghosts as a model for biological
membranes. By employing ghosts, we could rule out any
loss of EPR intensity due to reduction of the NO moiety of
SL-PC by endogenous redox reactions, which would com-
plicate the assessment of transbilayer distribution of ana-
logs. For example, it has been shown that spin-labeled lipid
analogs with the NO moiety close to the headgroup are
rapidly reduced on the cytoplasmic, but not on the exoplas-
mic leaflet of intact erythrocytes at 37°C (Seigneuret et al.,
1984). Presumably, cytosolic redox systems such as gluta-
thione were responsible, because no reduction of the NO
moiety was observed in erythrocyte ghosts (Zachowski et
al., 1986). We note that under certain conditions intracellu-
lar reduction can be employed to study the transbilayer
movement of those spin-labeled lipid analogs (Seigneuret et
al., 1984; Bitbol and Devaux, 1988; Muller et al., 1994).
First, we have determined the kinetics of the insertion of
the SL-PC into EPC and into red cell ghost membranes. In
both cases the kinetics of analog incorporation could not be
fit by a single exponential. At least a biexponential function
was required to provide a reasonable fit of the kinetics (see
Fig. 3). Ninety percent of the SL-PC molecules became
incorporated into EPC and red cell ghost membranes within
5 s at room temperature. The half-time reported for the
fastest transbilayer distribution known is 20 s (see above).
Therefore we conclude that incorporation of spin-labeled
phospholipid analogs like SL-PC does not limit the time
resolution of assays to measurement of rapid transbilayer
movement. Because the kinetics of incorporation of SL-PC
into EPC and into ghost membranes are very similar, we
surmise that the specific composition of membranes, in
particular membrane proteins, does not significantly influ-
ence the rate of the repartition process. However, this must
be carefully proved for each membrane system under study.
Elucidation of the mechanism of SL-PC repartition into
membranes was beyond the scope of this study. Further
detailed studies are warranted to investigate the transfer of
the spin-labeled phospholipid analog from aqueous suspen-
sion to membranes. Several mechanisms that do not exclude
each other must be considered, e.g., incorporation of analog
as a monomer via the aqueous phase, and/or collision
and subsequent fusion of micelles with the respective
membranes.
Next we employed stopped-flow EPR spectroscopy to
elucidate the time resolution that can be achieved with the
ascorbate and back-exchange assays. Reduction of SL-PC
the incorporation of the phospholipid analogs into the mem-
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in the outer leaflet of EPC vesicles by 50 mM ascorbate was
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completed within -60 s at room temperature. The reduction
reaction was pseudo-first-order with respect to SL-PC. The
half-time t112 was --10 s. Of course, t112 was dependent on
the ascorbate concentration, as demonstrated by its fivefold
decrease upon an increase in the ascorbate concentration to
250 mM (data not shown). However, considering the native
environment of biological membranes (ionic strength, os-
motic pressure, etc.), we regard an ascorbate concentration
of 50 mM as an upper limit. Ascorbate-mediated reduction
of SL-PC that had been incorporated into red cell ghost
membranes also followed pseudo-first-order kinetics. How-
ever, t1/2 of the reduction at comparable conditions was
slower than that obtained in the case of EPC vesicle mem-
branes (tl2 = 14.5 s). Presumably, the rate of the reduction
process is affected by the membrane composition, e.g., by
the presence of negatively charged groups on the membrane
surface. For example, anionic residues of the glycocalyx
(such as sialic acids), as well as negatively charged phos-
pholipids (like phosphatidylserine), may lower the effective
concentration of the negatively charged ascorbate ions on
the membrane surface by electrostatic repulsion (Schreier-
Mucillo et al., 1976; Auland et al., 1994). From these results
we surmise that the time resolution provided by ascorbate
reduction of spin-labeled phospholipids is on the order of
the half-time of the rapid transbilayer movements men-
tioned above and, thus, may cause serious limitations for
assaying transbilayer distribution.
One way to improve the time resolution of the ascorbate
assay is to replace ascorbate by a more potent reducing
agent. We found that when SL-PC that resides in the outer
leaflet of EPC vesicles is reduced by the ascorbic acid
derivative 6-0-phenyl-ascorbic acid at room temperature,
the reduction rate increases significantly in comparison to
that of ascorbate. The calculated first-order rate constants kr
for the reduction by ascorbate and 6-0-phenyl-ascorbic acid
differ by -30-fold (see Table 1). This may be due to the fact
that 6-0-phenyl-ascorbic acid is less polar than ascorbate
and may therefore partly partition into the bilayer, which
would raise its effective membrane concentration signifi-
cantly. The latter is supported in that we found no improve-
ment of the time resolution when using the more hydro-
philic ascorbic acid derivative 6-amino-ascorbic acid in
place of ascorbate (data not shown). By using symmetrically
labeled EPC vesicles, we could show that ascorbate does not
penetrate through EPC bilayers at room temperature. How-
ever, we found evidence for permeation of 6-0-phenyl
ascorbic acid at room temperature. Permeation of 6-0-
phenyl ascorbic acid across the membrane bilayer may
cause a serious disadvantage, because it may hamper or
even make it impossible to obtain meaningful results on the
transbilayer distribution of analogs in membrane systems
other than EPC vesicles. Nevertheless, the permeability of
EPC membranes to 6-0-phenyl ascorbic acid was still suf-
ficiently slow to allow determination of the transbilayer
distribution of SL-PC in symmetrically labeled vesicles by
simple extrapolation. Moreover, Wu and Hubbell (1993)
useful when the permeability of the reducing agent does not
allow a simple (graphical) determination of the amount of
analogs residing on the inner leaflet. The model takes into
account the rate constants of reduction as well as of perme-
ation of the reducing agent and allows an accurate determi-
nation of the transbilayer distribution. Permeation of 6-0-
phenyl ascorbic acid did not occur when the reduction was
performed at lower temperature. It could be shown that at
0°C 6-O-phenyl-ascorbic acid did not permeate EPC bilay-
ers, whereas reduction of SL-PC on the outer leaflet of
symmetrically labeled EPC vesicles was still very rapid
(data not shown).
The transbilayer distribution of SL-PC determined for
symmetrically labeled small unilamellar EPC vesicles with
either ascorbate or 6-O-phenyl ascorbic acid was about
one-third on the inner leaflet and two-thirds on the outer
leaflet. This value corresponds to the theoretical distribution
that can be derived mathematically for small unilamellar
vesicles for which the surface area of the inner membrane
leaflet is significantly smaller than that of the outer leaflet
(Thomas and Poznansky, 1989).
Because the membrane spectra of SL-PC in EPC vesicles
or ghosts were significantly different from the spectrum of
the analog bound to BSA, we were able to measure the time
course of the back-exchange of SL-PC from EPC vesicle
membranes and red cell ghost membranes to BSA by means
of stopped-flow EPR spectroscopy. To ensure complete
label extraction, we had to use a final concentration of 5%
(w/v) BSA. Lower concentrations resulted in an incomplete
extraction of the SL-PC from the membrane. We note that
the kinetics of SL-PC extraction could not be fitted by a
single exponential. However, investigation of the underly-
ing mechanism was beyond the scope of our study. Because
the kinetics of extraction of SL-PC from the membrane of
EPC vesicles and ghosts were almost identical, the presence
of membrane proteins does not seem to be a major deter-
minant of the extraction process. We found that 90% of the
SL-PC molecules were extracted by 5% (w/v) BSA (final
concentration) within 15 s at room temperature. Conse-
quently, the half-time of the back-exchange assay is signif-
icantly shorter than that of the reduction assay employing
ascorbate. One may therefore prefer the back-exchange
approach, particularly in the case of rapid transbilayer
movement. However, we must emphasize that standard pro-
tocols for this assay usually require a time-consuming cen-
trifugation step to separate the BSA from the membranes for
subsequent spectroscopic measurement of the supernatant.
This step, but not the time course of analog extraction from
the membrane, significantly limits the time resolution of the
method. Buton et al. (1996) demonstrated that by combining
the back-exchange procedure with a rapid filtration assay, a
time resolution of -30 s can be achieved. But this must be
regarded as the maximum achievable time resolution. In
contrast, reduction methods like the ascorbate assay do not
require a centrifugation step. The time resolution is deter-
mined solely by the kinetics of the reduction reaction. The
Marx et al. 1 653
have described a mathematical model that is particularly
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main difficulty with the assay is controlling penneation of
the reducing agent across the membrane bilayer.
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